T-DXd has been demonstrated to increase tumor-infiltrating dendritic cells and upregulate the expression of their maturation and activation markers, increase tumor-filtered CD8+ T cells, and enhance the expression of PD-L1 and MHC class I on tumor cells [92,93]. The gene discussed is CD274; the disease is neoplasm.